Resistin increases platelet P-selectin levels via p38 MAPK signal pathway

Diabetes and Vascular Disease Research

Volumn 11, Issue 2, 2014, Pages 121-124

  Qiu, Wenbing ^a   Chen, Naping ^a   Zhang, Qin ^a   Zhuo, Liyuan ^a   Wang, Xihong ^a   Wang, Dongming ^a   Jin, Hong ^a,b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

P selectin; p38 MAPK; platelet; Resistin

Indexed keywords

P-SELECTIN; P38 MAPK; PLATELET; RESISTIN;

ANIMALS; BLOOD PLATELETS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MICE; P-SELECTIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RESISTIN; SIGNAL TRANSDUCTION;

EID: 84894499874     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164113513912     Document Type: Article

References (10)

1. Grundy SM, Brewer HB JR, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109: 433-438
2. Dentali F, Squizzato A, Caprioli M, et al. Prevalence of arterial and venous thromboembolic events in diabetic patients with and without the metabolic syndrome: a cross sectional study. Thromb Res. 2011; 127: 299-302
3. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001; 409: 307-312
4. Fain JN, Cheema PS, Bahouth SW, et al. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun. 2003; 300: 674-678
5. Langheim S, Dreas L, Veschini L, et al. Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am J Physiol Heart Circ Physiol. 2010; 298: H746 - H753
6. Scialla JJ, Plantinga LC, Kao WH, et al. Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients. Am J Nephrol. 2011; 33: 224-230
7. Ay C, Tengler T, Vormittag R, et al. Venous thromboembolism - a manifestation of the metabolic syndrome. Haematologica. 2007; 92: 374-380
8. Santilli F, Vazzana N, Liani R, et al. Platelet activation in obesity and metabolic syndrome. Obes Rev. 2012; 13: 27-42
9. Pirvulescu M, Manduteanu I, Gan AM, et al. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation. Biochem Biophys Res Commun. 2012; 422: 321-326
10. Chen WF, Lee JJ, Change CC, et al. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets. Haematologica. 2013; 98: 793-801